相关实验视频
Updated: Jul 11, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
在差分化甲状腺癌中基因组变化的表征
Yeeun Lee1, SeongRyeol Moon2, Jae Yeon Seok3
1Department of Genome Medicine and Science, AI Convergence Center for Medical Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Dokjeom-ro 3Beon-gil, 38-13, Namdong-gu, Incheon, 21565, Republic of Korea.
差差分化甲状腺癌 (PDTC) 的基因组分析揭示了RAF1,MAP2K2和AKT2.2中的新遗传变异. 这些发现提供了对PDTC进展和潜在治疗点的见解.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 差差分化甲状腺癌 (PDTC) 由于转移和复发率高,因此具有重大临床挑战.
- 对于PDTC存在有限的全蛋白编码基因规模研究,这阻碍了对其分子基础的全面理解.
研究的目的:
- 对PDTC进行全面的基因组分析.
- 识别与PDTC进展和临床病理学相关的遗传变异.
- 探索PDTC的潜在新型治疗点.
主要方法:
- 在15名PDTC患者身上进行了整体外基因组测序.
- 对三名患者进行了差异表达基因 (DEGs) 的基因功能丰富分析.
- 进行了体质突变与临床病理特征之间的关联分析.
主要成果:
- 确定了RAF1,MAP2K2和AKT2的体内基因组变化,此前没有在PDTC中报告过.
- 证实了频繁发生的RAS基因变异,与RAS-RAF-MEK-ERK/JNK,PI3K-AKT-mTOR通路和细胞周期有关.
- 与正常组织相比,DEG分析表明PDTC组织的免疫反应被抑制.
- 在ABCA12,CLIP1和ATP13A3的体质突变与血管入侵有显著的关联.
结论:
- 这项研究为PDTC提供了新的分子遗传见解.
- 已确定的基因变异和途径为未来的PDTC疗法提供了潜在的点.
- 这些发现可能有助于改善PDTC的诊断和治疗策略.
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancers Originate from Somatic Mutations in a Single Cell

